loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of All Manufacturers & Suppliers for 50719 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 BISMUTH SUBSALICYLATE; METRONIDAZOLE; TETRACYCLINE HYDROCHLORIDE (1)

filter

01 CASPER PHARMA LLC (1)

filter

01 TABLET, CHEWABLE, TABLET, CAPSULE;ORAL (1)

filter

01 262.4MG,N/A,N/A;N/A,250MG,N/A;N/A,N/A,500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)

filter

01 USA (1)

URL Supplier Web Content
TABLET, CHEWABLE, TABL...
262.4MG,N/A,N/A;N/A,25...
HELIDAC
USA
50719
1996-08-15
DISCN
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 50719

Looking for CTD TGA MCC DOSSIER APPLICATION 50719 1

19

DELCOR ASSET, based in U.S.A, is a pharmaceutical company.

One of their notable products is BISMUTH SUBSALICYLATE; METRONIDAZOLE; TETRACYCLINE HYDROCHLORIDE, with a corresponding application number 50719 and regulatory information .

proudly manufactured in the

approval since 1996-08-15

DELCOR ASSET's HELIDAC TABLET, CHEWABLE, TABLET, CAPSULE;ORAL, medication with 262.4MG,N/A,N/A;N/A,250MG,N/A;N/A,N/A,500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** of BISMUTH SUBSALICYLATE; METRONIDAZOLE; TETRACYCLINE HYDROCHLORIDE.

Post Enquiry
POST ENQUIRY